Pityriasis rosea after administration of copyright-BioNTech COVID-19 vaccine

Pityriasis rosea after administration of copyright-BioNTech COVID-19 vaccine

Blog Article

Pityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a cmpk bolus widespread rash along skin cleavage lines.Although the exact pathogenesis of PR is unknown, current evidence suggests that an inflammatory reaction due to a viral trigger may lead to the cutaneous manifestations.COVID-19 has been reported as one such viral trigger for PR.Previously, PR has been reported in temporal association with various viral inoculations.

This article presents a brazmallows hyde flavor case of PR in a 66-year-old black male 1 week after administration of the copyright-BioNTech COVID-19 vaccine.